Chesnara Plc: Fourth acquisition in two years
12 November 2026
Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector specializing in medical devices, stands at a pivotal moment as it navigates a challenging market..
Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a promising name in the biotechnology sector, has been capturing investor attention with its ambitious pipeline of treatments targeting severe autoimmune..
Sage Therapeutics, Inc. (NASDAQ: SAGE), a beacon in the biotechnology sector, is captivating investor attention with its impressive 78% revenue growth. Headquartered in Cambridge, Massachusetts, Sage..
ATAI Life Sciences N.V. (NASDAQ: ATAI), a player in the burgeoning field of mental health pharmaceuticals, is capturing investor attention with its impressive potential upside. Currently..
Fortrea Holdings Inc. (FTRE), a prominent player in the biotechnology sector, has caught the attention of investors with a compelling 38.20% potential upside. As a contract..
Investors eyeing Cross Country Healthcare, Inc. (CCRN) will find themselves at a crossroads, evaluating the potential for a significant upside against the backdrop of current market..
SIGA Technologies Inc. (NASDAQ: SIGA) is a noteworthy player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With a market..
For investors with a keen eye on the healthcare sector, Neuropace, Inc. (NASDAQ: NPCE) stands out as an intriguing prospect. Known for its pioneering work in..
REGENXBIO Inc. (NASDAQ: RGNX) stands as a notable player within the biotechnology sector, a domain known for its dynamic nature and high potential for growth. The..
For those keeping a keen eye on healthcare stocks, Organogenesis Holdings Inc. (NASDAQ: ORGO) presents a compelling investment narrative. With a market capitalization of $553.08 million,..
Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of $502.09 million,..
Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the biotechnology sector, not only for its innovative treatment offerings but also for its intriguing financial prospects. With..
AxoGen, Inc. (NASDAQ: AXGN), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with a compelling potential upside of 108.82%...
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) has captured investor attention with its significant potential upside, as analysts forecast a remarkable 112.66% increase from its current price. Specializing..
Cel-Sci Corporation (NYSEAMERICAN: CVM), a clinical-stage biotechnology firm based in Vienna, Virginia, is making waves in the healthcare sector with its innovative approach to cancer treatment..
Bicara Therapeutics Inc. (NASDAQ: BCAX) is capturing the attention of savvy investors within the biotechnology sector, promising a striking potential upside of 179.83%. As a clinical-stage..
LifeMD, Inc. (NASDAQ: LFMD) stands at the confluence of healthcare innovation and digital transformation, offering an intriguing opportunity for investors looking to capitalize on the growth..
COMPASS Pathways Plc (NASDAQ: CMPS) is garnering attention in the healthcare sector for its pioneering work in mental health treatments. With a current market capitalization of..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) has emerged as a noteworthy player within the biotech sector, particularly for investors looking to capitalize on the potential of rare..
Claritev Corporation (NASDAQ: CTEV) operates in the dynamic healthcare sector, specifically within health information services. Based in New York, Claritev is a pivotal player in providing..
